Newly Discovered Process Of Cell Death Shows Promise In The Treatment Of All Forms Of Cancer
7/11/2011
According to an article published recently in the online journal Molecular Cell, researchers from the Breakthrough Breast Cancer Research Centre at The Institute of Cancer Research (ICR) in London, have found a new technique for eliminating cancer cells. This new approach can prove to be highly effective in the treatment all types of cancer...
International Research Team Find Breakthrough In Fighting The Deadliest Cancer
7/11/2011
An international research team from Barts Cancer Institute (BCI) has found that Vitamin A could hold the key to beating pancreatic cancer which has the lowest survival rate of all cancers, claiming a quarter of a million lives worldwide each year...
Nuvilex Announces Successful Breast Cancer Preclinical Studies
7/11/2011
Nuvilex, Inc. (OTCQB: NVLX) announced today successful results for the treatment of breast cancer from preclinical studies. In recently completed work using the Nuvilex live-cell encapsulation technology and a combination of two anticancer drugs, clear positive results of elimination of breast tumors were achieved in preclinical models...
Multi-Institutional Genetic Landmark Study Of Ovarian Cancer
7/11/2011
A University of Houston researcher is an author on a landmark multi-institutional genetic study of the most aggressive and common form of ovarian cancer that is published in the current issue of the scientific journal Nature. Ovarian cancer is the fifth-leading cause of cancer death in women in the United States...
A new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society has reported that low compliance by healthcare providers to the current guidelines for the treatment of high-grade noninvasive bladder cancer is resulting in incomplete care of patients with the disease...
Research Targets Malignant Glioma Stem Cells
7/11/2011
Cleveland Clinic researchers have identified a cellular pathway that cancer stem cells use to promote tumor growth in malignant glioma, an aggressive brain tumor. The research - published in Cell - also found that existing medications block this cancer-promoting pathway and delay glioma growth in animal models, suggesting a new treatment option for these often fatal brain tumors...
Thought-Provoking Article On 'Pinkwashing' In Environmental Justice
7/10/2011
Companies that try to increase sales of their products by adopting the color pink and pink ribbons to imply that they support breast cancer research - a practice called pinkwashing - but at the same time permit the use of chemicals shown to cause cancer are committing a form of social injustice against women, according to a thought-provoking article in Environmental Justice, a ...
Novartis Pharmaceuticals Corporation ("Novartis") announced Phase III trial results that showed more than one-third of patients taking Afinitor® (everolimus) tablets experienced a 50% or greater reduction in the size of their subependymal giant cell astrocytomas (SEGAs), non-cancerous brain tumors associated with tuberous sclerosis complex (TSC)(1,2,6)...
Risk Of Clotting Disorders After Knee Surgery May Be Increased By Previous Cancer History
7/09/2011
A history of cancer was a significant risk factor for developing blood clotting issues following knee arthroscopy, according to a study presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Researchers from the Mayo Clinic in Rochester, Minnesota analyzed the records of more than 12,000 patients who had undergone the common knee procedure...
Targeted Agent Addition To Herceptin Has Positive Effect On Metastatic HER-2 Breast Cancer
7/09/2011
Adding Afinitor® to Herceptin®, the main treatment for HER2-positive metastatic breast cancer, helps some women with disease that has been resistant to previous Herceptin-based therapies, according to a study led by researchers at The University of Texas MD Anderson Cancer Center and published in the Journal of Clinical Oncology...